202 related articles for article (PubMed ID: 25568316)
1. Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain.
Vaughan AT; Chan CH; Klein C; Glennie MJ; Beers SA; Cragg MS
J Biol Chem; 2015 Feb; 290(9):5424-37. PubMed ID: 25568316
[TBL] [Abstract][Full Text] [Related]
2. Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy.
Lim SH; Vaughan AT; Ashton-Key M; Williams EL; Dixon SV; Chan HT; Beers SA; French RR; Cox KL; Davies AJ; Potter KN; Mockridge CI; Oscier DG; Johnson PW; Cragg MS; Glennie MJ
Blood; 2011 Sep; 118(9):2530-40. PubMed ID: 21768293
[TBL] [Abstract][Full Text] [Related]
3. Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells.
Beum PV; Peek EM; Lindorfer MA; Beurskens FJ; Engelberts PJ; Parren PW; van de Winkel JG; Taylor RP
J Immunol; 2011 Sep; 187(6):3438-47. PubMed ID: 21841127
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Fcgamma receptor-mediated phagocytosis by a nonphagocytic Fcgamma receptor.
Hunter S; Indik ZK; Kim MK; Cauley MD; Park JG; Schreiber AD
Blood; 1998 Mar; 91(5):1762-8. PubMed ID: 9473244
[TBL] [Abstract][Full Text] [Related]
5. Internalization of rituximab and the efficiency of B Cell depletion in rheumatoid arthritis and systemic lupus erythematosus.
Reddy V; Cambridge G; Isenberg DA; Glennie MJ; Cragg MS; Leandro M
Arthritis Rheumatol; 2015 May; 67(8):2046-55. PubMed ID: 25916583
[TBL] [Abstract][Full Text] [Related]
6. FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
Simpson AP; Roghanian A; Oldham RJ; Chan HTC; Penfold CA; Kim HJ; Inzhelevskaya T; Mockridge CI; Cox KL; Bogdanov YD; James S; Tutt AL; Rycroft D; Morley P; Dahal LN; Teige I; Frendeus B; Beers SA; Cragg MS
Cell Rep; 2022 Jul; 40(3):111099. PubMed ID: 35858562
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity.
Vaughan AT; Iriyama C; Beers SA; Chan CH; Lim SH; Williams EL; Shah V; Roghanian A; Frendéus B; Glennie MJ; Cragg MS
Blood; 2014 Jan; 123(5):669-77. PubMed ID: 24227819
[TBL] [Abstract][Full Text] [Related]
8. Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.
Boonnak K; Slike BM; Donofrio GC; Marovich MA
J Immunol; 2013 Jun; 190(11):5659-65. PubMed ID: 23616574
[TBL] [Abstract][Full Text] [Related]
9. Both activating and inhibitory Fc gamma receptors mediate rituximab-induced trogocytosis of CD20 in mice.
Boross P; Jansen JH; Pastula A; van der Poel CE; Leusen JH
Immunol Lett; 2012 Mar; 143(1):44-52. PubMed ID: 22285696
[TBL] [Abstract][Full Text] [Related]
10. Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors.
Wang LH; Wang N; Lu XY; Liu BC; Yanda MK; Song JZ; Dai HM; Sun YL; Bao HF; Eaton DC; Ma HP
Biochim Biophys Acta; 2012 Feb; 1823(2):505-13. PubMed ID: 22192444
[TBL] [Abstract][Full Text] [Related]
11. Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.
Beers SA; French RR; Chan HT; Lim SH; Jarrett TC; Vidal RM; Wijayaweera SS; Dixon SV; Kim H; Cox KL; Kerr JP; Johnston DA; Johnson PW; Verbeek JS; Glennie MJ; Cragg MS
Blood; 2010 Jun; 115(25):5191-201. PubMed ID: 20223920
[TBL] [Abstract][Full Text] [Related]
12. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
[TBL] [Abstract][Full Text] [Related]
13. Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.
Jiang VC; Liu Y; Jordan A; Leeming A; McIntosh J; Huang S; Zhang R; Cai Q; Chen Z; Li Y; Che Y; Nie L; Karlsson I; Mårtensson L; Kovacek M; Teige I; Frendéus B; Wang M
J Hematol Oncol; 2022 Apr; 15(1):42. PubMed ID: 35410313
[TBL] [Abstract][Full Text] [Related]
14. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA.
Huang ZY; Hunter S; Kim MK; Indik ZK; Schreiber AD
J Leukoc Biol; 2003 Jun; 73(6):823-9. PubMed ID: 12773515
[TBL] [Abstract][Full Text] [Related]
15. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
[TBL] [Abstract][Full Text] [Related]
16. Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells.
Hartholt RB; Wroblewska A; Herczenik E; Peyron I; Ten Brinke A; Rispens T; Nolte MA; Slot E; Claassens JW; Nimmerjahn F; Verbeek JS; Voorberg J
J Thromb Haemost; 2017 Feb; 15(2):329-340. PubMed ID: 27868337
[TBL] [Abstract][Full Text] [Related]
17. FcγRIIB as a key determinant of agonistic antibody efficacy.
White AL; Beers SA; Cragg MS
Curr Top Microbiol Immunol; 2014; 382():355-72. PubMed ID: 25116108
[TBL] [Abstract][Full Text] [Related]
18. Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.
Sundgren NC; Zhu W; Yuhanna IS; Chambliss KL; Ahmed M; Tanigaki K; Umetani M; Mineo C; Shaul PW
Circ Res; 2011 Oct; 109(10):1132-40. PubMed ID: 21940940
[TBL] [Abstract][Full Text] [Related]
19. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
[TBL] [Abstract][Full Text] [Related]
20. Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.
Hatjiharissi E; Hansen M; Santos DD; Xu L; Leleu X; Dimmock EW; Ho AW; Hunter ZR; Branagan AR; Patterson CJ; Kortsaris A; Verselis S; Fox E; Treon SP
Clin Lymphoma Myeloma; 2007 Jan; 7(4):286-90. PubMed ID: 17324336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
